Aluminum Chloride Hexahydrate; Used To Treat Hyperhidrosis, Excessive Sweating
Aluminum chloride hexahydrate is soluble in wide range of
solvents, such as ether, chloroform, propylene glycol, ethanol, and water. It
has low melting and boiling points, non-flammable, and exhibits good electrical
conduction. It is produced by dissolution of aluminum oxide in hydrochloric
acid. Aluminum chloride hexahydrate is widely used in the metal processing and
pharmaceutical industries. It is used to manufacture aluminum metal, as a
catalyst in chemical synthesis. Nowadays, it is being used in water treatment
areas as well.
Aluminum
chloride hexahydrate is used to treat hyperhidrosis, excessive sweating. It
works as an antiperspirant that works by affecting sweat-producing cells. Some
studies claim that it may cause breast cancer because it has carcinogenic
properties. However, these claims have not been validated due to sufficient
evidence. Aluminum chloride hexahydrate is one of the most commonly used
chemicals for corrosion resistance. It is also used in the automotive industry
for protecting and strengthening the connections of internal combustion engine
components such as cylinders and piston bearings.
The main properties of aluminum chlorate hexahydrate that
gives it its corrosion resistant properties is due to the intensions of the
molecule. When the molecules of this compound are in their liquid state, the
hydrogen bonding between them becomes stronger and leads to increased friction
and fewer break-up points. When these properties are applied on steel, it helps
to reduce corrosion to a great extent. In fact, there have been numerous
patents filed on this technology and more are on the way.
Hyperhidrosis is the most common skin condition that
severely impacts the quality of life of affected patients. Aluminum chloride
hexahydrate is considered first-line treatment for patients with mild-to-moderate
hyperhidrosis. Moreover, demand for aluminum chloride hexahydrate is increasing
significantly due to the rapidly growing pharmaceutical and consumer goods
market. According to the Pharmaceutical Research and Manufacturers of America,
U.S. firms conduct over half the world's R&D in pharmaceuticals (US$75
billion) and hold the intellectual property rights on most new medicines.
Comments
Post a Comment